市值76亿!红杉投出一个IPO

猎云网
21 Mar

来源:直通IPO,文/韩文静港股市场,迎来了“生长激素第一股”。3月21日,维升药业登陆港交所,发行价格为每股68.80港元,开盘平开;截至发稿每股跌1.74%至67.6港元,总市值76.01亿。公司于2018年11月成立,是一家处于研发后期、产品接近商业化的生物制药公司,专注于在中国(包括香港、澳门及台湾)提供特定内分泌疾病的治疗方案。维升药业拥有一款核心产品及两款其他在研候选药物。核心产品...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10